// COMPANY
Apnimed
SECTOR HEALTHTECHMENTIONS 2LAST SEEN AUGUST 3, 2026
// OVERVIEW
Cambridge, MA-based developer of a pill for obstructive sleep apnea
Discussed in
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
funding·PitchBook News·AUGUST 3, 2026
“Apnimed...raised $192 million in its Nasdaq IPO, pricing 12 million shares at $16.”
Source→02
funding·Axios Pro Rata·JULY 31, 2026
“Raised $192m in its IPO. It priced 12m shares at $16, versus plans to offer 10m shares at $14-$16.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.